OMEICOS Therapeutics

OMEICOS Therapeutics
OMEICOS Therapeutics
OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS’ novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS’ substances activate an endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Berlin
BioTech, Therapeutics, Healthcare
2013
www.omeicos.com

Articles about OMEICOS Therapeutics:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as OMEICOS Therapeutics? We’re happy to assist you with our Startup Sourcing service.